Jublia

Chemical Nameefinaconazole
Dosage FormSolution (topical; 10%)
Drug ClassAntifungals
SystemSkin
CompanyBausch Health
Approval Year2014

Indication

  • For the treatment of onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes.
Last updated on 7/18/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Jublia (efinaconazole) Prescribing Infromation.2022Bausch Health US, LLC, Bridgewater, NJ
Document TitleYearSource
Topical and device-based treatments for fungal infections of the toenails (review). 2020Cochrane Database of Systematic Reviews